What's new

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised

Jun 18, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Supreme Court ruling on gender-affirming care delivers major setback for transge...

Next Article

Human medicines European public assessment report (EPAR): Pergoveris, follitropi...

Related Posts

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, atropine, Status: Opinion under re-examination

Human medicines European public assessment report (EPAR...

Jun 3, 2025  0

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 26, 2025  0

Concept paper on the development of a guideline on cons...

May 23, 2025  0